CareLit · DOI-Nachweis · Pädiatrische Praxis
Targeted therapy with the antibody-drug conjugate sacituzumab-govitecan as a promising treatment strategy for head and neck squamous cell carcinoma
DOI 10.1055/s-0044-1784758
Bibliografische Angaben
Nachweis in CareLit
Autor:innenAlexander Philippe Maas, Christine Sanders, Nina Marie Gredig, Jonas Eckrich, Benjamin Ernst, Niklas Klümper, Eduard Below, Glen Kristiansen, Dimo Dietrich, Sebastian Strieth
ZeitschriftPädiatrische Praxis
Ausgabe05/2024
Jahrgang / SeitenJg. 103 · S. S231
Kernaussage aus der Literatur
Abstract-Vorschau
Targeted therapy with the antibody-drug conjugate sacituzumab-govitecan as a promising treatment strategy for head and neck squamous cell carcinoma
Zitieren
Zitierempfehlung
Alexander Philippe Maas, Christine Sanders, Nina Marie Gredig, Jonas Eckrich, Benjamin Ernst, Niklas Klümper, Eduard Below, Glen Kristiansen, Dimo Dietrich, Sebastian Strieth (2024) Targeted therapy with the antibody-drug conjugate sacituzumab-govitecan as a promising treatment strategy for head and neck squamous cell carcinoma. Pädiatrische Praxis, 103 (05), S231. https://doi.org/10.1055/s-0044-1784758
Mit CareLit weiterarbeiten